![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-9-2020-1600260117.pdf
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-initiates-voluntary-nationwide-recall-four-lots-amiodarone-hcl-injection-usp-and-tranexamic#:~:text=Mylan%20N.V.%20(NASDAQ%3A%20MYL),Injection%2C%20USP%201000%20mg%2F10
https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-four-lots-of-amiodarone-hcl-injection-usp-and-tranexamic-acid-injection-usp-due-to-carton-label-mix-up-301120584.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213446
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213446
https://www.pharmacompass.com/pdf/news/baxter-expands-voluntary-nationwide-recall-to-include-second-lot-of-nexterone-injection-due-to-presence-of-particulate-matter-1587013079.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-4-2019-1575442774.pdf
http://www.pharmatimes.com/news/nhs_england_scraps_7_more_drugs_on_prescription_1293506
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2018-1517980699.pdf
https://www.pharmacompass.com/pdf/news/baxter-expands-voluntary-nationwide-recall-to-include-second-lot-of-nexterone-injection-1516164457.pdf
https://www.pharmacompass.com/pdf/news/baxter-issues-a-voluntary-nationwide-recall-for-one-lot-of-nexterone-injection-1510721652.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204550
https://www.druganddevicelawblog.com/2017/10/double-preemption-win-in-amiodarone-litigation.html
https://www.pharmacompass.com/pdf/news/aurobindos-generic-amiodarone-hydrochloride-approved-in-us-for-cardiac-dysrhythmias-1465303059.pdf
http://www.bloomberg.com/news/articles/2015-11-04/gilead-s-sovaldi-tied-to-slow-heartbeat-in-hepatitis-c-patients?
http://www.pmlive.com/pharma_news/bms_opdivo_backed_as_melanoma_therapy_in_eu_721486
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/04/news_detail_002310.jsp&mid=WC0b01ac058004d5c1
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/04/news_detail_002313.jsp&mid=WC0b01ac058004d5c1
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/52801a-eng.php
http://pipeline.corante.com/archives/2015/04/01/trouble_with_sovaldi_or_not.php
http://www.mercurynews.com/business/ci_27775353/gilead-hepatitis-c-drug-approved-canadian-health-plan?source=infinite
http://www.fiercepharma.com/story/cipla-revs-generic-sovaldi-launch-india/2015-03-25
http://www.fda.gov/Drugs/DrugSafety/ucm439484.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery